Mani R. Moniri
Mani R. Moniri
Bilinmeyen bağlantı
mh.org.au üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Potential implications of mesenchymal stem cells in cancer therapy
LJ Dai, MR Moniri, ZR Zeng, JX Zhou, J Rayat, GL Warnock
Cancer letters 305 (1), 8-20, 2011
1392011
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer
K Dalal, M Roshan-Moniri, A Sharma, H Li, F Ban, M Hessein, M Hsing, ...
Journal of biological chemistry 289 (38), 26417-26429, 2014
1012014
Dynamic assessment of cell viability, proliferation and migration using real time cell analyzer system (RTCA)
MR Moniri, A Young, K Reinheimer, J Rayat, LJ Dai, GL Warnock
Cytotechnology 67 (2), 379-386, 2015
982015
TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
MR Moniri, XY Sun, J Rayat, D Dai, Z Ao, Z He, CB Verchere, LJ Dai, ...
Cancer gene therapy 19 (9), 652-658, 2012
722012
Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment
E Hosseini-Beheshti, W Choi, LB Weiswald, G Kharmate, M Ghaffari, ...
Oncotarget 7 (12), 14639, 2016
602016
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
BWC Tse, M Volpert, E Ratther, N Stylianou, M Nouri, K McGowan, ...
Oncogene 36 (24), 3417-3427, 2017
492017
Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1
AK Marr, H Jenssen, MR Moniri, REW Hancock, N Panté
Biochimie 91 (1), 160-164, 2009
492009
MSCTRAIL-mediated HepG2 cell death in direct and indirect co-cultures
XY Sun, J Nong, K Qin, H Lu, MR Moniri, LJ Dai, GL Warnock
Anticancer research 31 (11), 3705-3712, 2011
462011
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
M Nouri, J Caradec, AA Lubik, N Li, BG Hollier, M Takhar, ...
Oncotarget 8 (12), 18949, 2017
382017
Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers
M Roshan-Moniri, M Hsing, MS Butler, A Cherkasov, PS Rennie
Cancer treatment reviews 40 (10), 1137-1152, 2014
352014
The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells
MR Moniri, LJ Dai, GL Warnock
Cancer gene therapy 21 (1), 12-23, 2014
332014
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
MS Butler, M Roshan-Moniri, M Hsing, D Lau, A Kim, P Yen, M Mroczek, ...
Cancer Research 77 (13 Supplement), 130-130, 2017
282017
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
MS Butler, M Roshan-Moniri, M Hsing, D Lau, A Kim, P Yen, M Mroczek, ...
Cancer Research 77 (13 Supplement), 130-130, 2017
282017
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
MS Butler, M Roshan-Moniri, M Hsing, D Lau, A Kim, P Yen, M Mroczek, ...
Cancer Research 77 (13 Supplement), 130-130, 2017
282017
Use it or lose it? Sablefish, Anoplopoma fimbria, a species representing a fifth teleostean group where the βNHE associated with the red blood cell adrenergic stress response …
JL Rummer, M Roshan-Moniri, SK Balfry, CJ Brauner
Journal of Experimental Biology 213 (9), 1503-1512, 2010
242010
Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer
K Dalal, F Ban, H Li, H Morin, M Roshan-Moniri, KJ Tam, A Shepherd, ...
Cancer letters 437, 35-43, 2018
232018
Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor–Chromatin Interactions
K Dalal, M Che, NS Que, A Sharma, R Yang, N Lallous, H Borgmann, ...
Molecular cancer therapeutics 16 (10), 2281-2291, 2017
182017
Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation
N Lallous, E Leblanc, RSN Munuganti, MDH Hassona, N Al Nakouzi, ...
Molecular cancer therapeutics 15 (12), 2936-2945, 2016
172016
Next generation biomarkers in prostate cancer
JA Locke, PC Black
therapy 17, 18, 2016
162016
Angiopoietin-like 4 Enhances the Proliferation and Migration of Tendon Fibroblasts.
S Jamil, R Mousavizadeh, M Roshan-Moniri, SJ Tebbutt, RG McCormack, ...
Medicine and science in sports and exercise 49 (9), 1769-1777, 2017
102017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20